« Back
Home /
RBN-3143

RBN-3143

Item no.	MOLN-M36022-500MG
Manufacturer	Molnova
CASRN	2360853-16-1
Amount	500 mg
Quantity options	100 mg 10 mg 1 g 25 mg 2 mg 500 mg 50 mg 5 mg
Specific against	other
Purity	>98% (HPLC)
Available
Molecular Weight	449, 54
Brief description	RBN-3143 is a potent inhibitor of NAD+-competitive catalytic PARP14 (IC50= 4 nM), which inhibits ADP-ribosylation mediated by PARP14 and stabilizes PARP14 in cell lines, demonstrating research potential for lung inflammation.
Note	Research use only, not for human use.
Stability	≥ 2 years
Receptor	PARP

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 500 mg

available

Delivery expected until 7/3/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail